Latest Series C+ Funding Rounds

Later-stage rounds, from Series C onwards, for companies expanding products, distribution and operations.

This page showsStage: Series C+
Rounds
572
All time
Disclosed funding
$283.5B
494 disclosed amounts
Median round
$126M
Of disclosed amounts
572 rounds
Funding rounds
CompanyAmountRoundSectorCountryInvestorsAnnounced
bit.bioBiotech · United KingdomCompany profile

Creates functional, human-relevant cells and models for research, drug discovery, and development

Creates functional, human-relevant cells and models for research, drug discovery, and development

$50MSeries CSeries C+BiotechUnited KingdomInvestors
FineHeartHealthtech · FranceCompany profile

Develops cardiology devices, including the fully implantable FlowMaker system.

Develops cardiology devices, including the fully implantable FlowMaker system.

€83MSeries CSeries C+HealthtechFranceInvestors
Luxury PresenceDeveloper tools · United StatesCompany profile

Luxury Presence provides an AI-based growth platform for real estate agents.

Luxury Presence provides an AI-based growth platform for real estate agents.

$37MSeries CSeries C+Developer toolsUnited StatesInvestors
CyeraCybersecurity · United StatesCompany profile

Provides a data security and AI governance platform helping enterprises control what AI can see and do

Provides a data security and AI governance platform helping enterprises control what AI can see and do

$400MSeries FSeries C+CybersecurityUnited StatesInvestors
ViCentraHealthtech · NetherlandsCompany profile

Develops and manufactures insulin patch pump systems for diabetes management

Develops and manufactures insulin patch pump systems for diabetes management

$13MSeries DSeries C+HealthtechNetherlandsInvestors
Parabilis MedicinesBiotech · United StatesCompany profile

Develops medicines targeting historically undruggable protein targets in cancer

Develops medicines targeting historically undruggable protein targets in cancer

$305MSeries FSeries C+BiotechUnited StatesInvestors
Rakuten MedicalBiotech · United StatesCompany profile

Develops and commercializes Alluminox platform-based photoimmunotherapy for cancer treatment

Develops and commercializes Alluminox platform-based photoimmunotherapy for cancer treatment

$100MSeries FSeries C+BiotechUnited StatesInvestors
Soley TherapeuticsBiotech · United StatesCompany profile

Uses cells as sensors to uncover first-in-class medicines

Uses cells as sensors to uncover first-in-class medicines

$200MSeries CSeries C+BiotechUnited StatesInvestors
SwapEcommerce · United KingdomCompany profile

Provides commerce operating system for brands to sell globally

Provides commerce operating system for brands to sell globally

$100MSeries CSeries C+EcommerceUnited KingdomInvestors
xAIAI · United StatesCompany profile

xAI develops the Grok family of AI models and applications for consumers, developers and organizations.

xAI develops the Grok family of AI models and applications for consumers, developers and organizations.

$20BSeries ESeries C+AIUnited StatesInvestors

Active investors in this selection

All investors →

Ranked by rounds participated in · All time

  1. 1
    Andreessen Horowitz (a16z)

    Isomorphic Labs, Northwood Space, Kalshi

    44rounds
    5led
  2. 2
    General Catalyst

    Mercor, Clara, Nominal

    44rounds
    1led
  3. 3
    Sequoia Capital

    Isomorphic Labs, LangChain, Nominal

    43rounds
    8led
  4. 4
    Lightspeed

    Payhawk, Nominal, Fractile

    39rounds
    7led
  5. 5
    NVIDIA

    Agile Robots, Mercor, fal

    36rounds
    0led

Latest digests

Archive →

Explore published rounds while the next edition is being prepared.

Browse rounds by topic